Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

GoPro Inc GPRO

GoPro, Inc. provides cameras, mountable and wearable accessories, and subscription and services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides HERO13 Black, HERO12 Black, HERO11 Black, HERO10 Black, HERO, and MAX cameras; Premium and Premium+ subscription, which are subscription services that include cloud storage for its content; and Quik subscription, a subscription service in total addressable market to those who value organizing the visual moments of their lives with footage from any phone or camera. It also offers mobile and web applications, and desktop plugins that provide a media workflow for archiving, editing, multi-clip story creation, and sharing content on the fly; and a lifestyle gear lineup that melds its signature design and versatility across a line of bags, backpacks, and cases, as well as a line of t-shirts, hats, and other soft goods. In addition, the company provides mounts and accessories; equipment-based mounts com...


NDAQ:GPRO - Post by User

<< Previous
Bullboard Posts
Next >>
User Avatar Image
(0)
•••
  • NatashaRomanX
Post by NatashaRomanon Apr 18, 2022 11:43pm
199 Views
Post# 34612164

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities